Personalized Kidney Cancer Vaccine

A groundbreaking study at Yale University has developed a personalized cancer vaccine that successfully reversed advanced kidney cancer in nine patients, leaving them disease-free for three years. The vaccine is tailored by analyzing the DNA and RNA of each patient's tumor to identify specific mutations, training the immune system to target and destroy cancer cells while sparing healthy tissue.